Mrs Kara S Cochran, PA | |
3600 Joseph Siewick Dr, Inova Fair Oaks Hospital, Fairfax, VA 22033-1709 | |
(703) 391-3842 | |
Not Available |
Full Name | Mrs Kara S Cochran |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 3600 Joseph Siewick Dr, Fairfax, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265609788 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0110002751 (Virginia) | Secondary |
363A00000X | Physician Assistant | 0110002751 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Kara S Cochran, PA 3600 Joseph Siewick Dr, Fairfax, VA 22033-1709 Ph: (703) 391-3842 | Mrs Kara S Cochran, PA 3600 Joseph Siewick Dr, Inova Fair Oaks Hospital, Fairfax, VA 22033-1709 Ph: (703) 391-3842 |
News Archive
Urinary catheters are often left in place longer than needed, and new research shows that reminder systems that encourage hospital staff to remove catheters promptly can reduce the rate of catheter-associated urinary tract infections by 52 percent.
Curcumin is a polyphenol compound produced by plants of the Curcuma longa species and has been reported to have many physiological activities, which include anti-oxidation, anti-inflammatory, anti-cancer, and anti-amyloid properties.
AHF's Magic Johnson ‘Testing America' Tour, a six month, 48 state national cross country HIV testing tour, will tumble into Albuquerque, New Mexico for a testing event at El Mezquite Market from 10am to 2pm Friday January 22nd. Free testing will take place on AHF's new, state-of-the-art ‘Testing America' mobile HIV testing unit. AHF is working in conjunction with New Mexico AIDS Services, a respected local non-profit HIV/AIDS organization.
Researchers have achieved an important scientific breakthrough in the fight against HIV and genital herpes with a vaginal gel that significantly reduces a woman's risk of being infected with these viruses. The results of the ground-breaking safety and effectiveness study of an antiretroviral microbicide gel study were reported today by the Centre for the AIDS Programme of Research in South Africa at the XVIII International AIDS Conference in Vienna, Austria.
The coronavirus disease (COVID-19) pandemic is rippling across the globe, with over 27.47 million reported cases. With the vast spread of the virus, scientists are racing to gain the approval of candidate vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 disease and Multisystem Inflammatory Syndrome in Children (MIS-C).
› Verified 1 days ago